| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
2019 Novel Coronavirus Disease
[description not available] | 0 | 2.6 | 1 | 0 |
Cognitive Decline
[description not available] | 0 | 2.6 | 1 | 0 |
Glial Cell Tumors
[description not available] | 0 | 2.6 | 1 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 3.37 | 4 | 0 |
Depression
Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. | 0 | 7.6 | 1 | 0 |
Glioma
Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) | 0 | 7.6 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 3.37 | 4 | 0 |
Cognitive Dysfunction
Diminished or impaired mental and/or intellectual function. | 0 | 7.6 | 1 | 0 |
Carcinogenesis
The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years. | 0 | 7.6 | 1 | 0 |
Hepatocellular Carcinoma
[description not available] | 0 | 2.6 | 1 | 0 |
Cancer of Liver
[description not available] | 0 | 2.6 | 1 | 0 |
Carcinoma, Hepatocellular
A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. | 0 | 2.6 | 1 | 0 |
Liver Neoplasms
Tumors or cancer of the LIVER. | 0 | 2.6 | 1 | 0 |
Arthritis, Degenerative
[description not available] | 0 | 2.6 | 1 | 0 |
Osteoarthritis
A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. | 0 | 7.6 | 1 | 0 |
Pericementitis
[description not available] | 0 | 2.6 | 1 | 0 |
Periodontitis
Inflammation and loss of connective tissues supporting or surrounding the teeth. This may involve any part of the PERIODONTIUM. Periodontitis is currently classified by disease progression (CHRONIC PERIODONTITIS; AGGRESSIVE PERIODONTITIS) instead of age of onset. (From 1999 International Workshop for a Classification of Periodontal Diseases and Conditions, American Academy of Periodontology) | 0 | 2.6 | 1 | 0 |
Lung Adenocarcinoma
[description not available] | 0 | 7.6 | 1 | 0 |
Cancer of Lung
[description not available] | 0 | 2.6 | 1 | 0 |
Adenocarcinoma of Lung
A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. | 0 | 2.6 | 1 | 0 |
Lung Neoplasms
Tumors or cancer of the LUNG. | 0 | 2.6 | 1 | 0 |
Adjuvant Arthritis
[description not available] | 0 | 2.25 | 1 | 0 |
Rheumatoid Arthritis
[description not available] | 0 | 2.25 | 1 | 0 |
Arthritis, Rheumatoid
A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. | 0 | 2.25 | 1 | 0 |